Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of meetings, online calls, and deadlines has predictably returned. This can only mean one thing — it is time to fire up the coffee kettle and quaff a few cups of stimulation. We are starting out with gingerbread spice. And of course, feel free to join us. Meanwhile, here are a few items of interest to stimulate your own neurons. We hope you have a smashing day and, as always, urge you to keep in touch. We enjoy your postcards and telegrams. …
The prospects for would-be Covid-19 vaccine manufacturers to prove their shots are protective are becoming ever slimmer, STAT explains. The world can now produce more Covid-19 vaccine than it needs or can administer — more than 12 billion doses a year. For a number of existing manufacturers, purchases have plateaued. Some are already scaling back production. A company hoping to enter the market with yet another vaccine that targets the original SARS-CoV-2 strain or that offers no advantages over existing products will be hard-pressed to find buyers. And demand for newer vaccines — products that are not as difficult to use as the mRNA vaccines — is either modest or stagnant.
Russia’s envoy to India maintains that the Indian pharmaceutical industry may replace Western manufacturers leaving the Russian market, The Hindustan Times writes. The newly appointed Russian envoy added that India is a “world pharmacy” and a leading manufacturer of drug copies that are no worse than the original. India has been under tremendous pressure to choose a side in the ongoing conflict between Russia and Ukraine as Western governments continue to impose harsher sanctions on Russia. India has abstained from voting on resolutions at the United Nations that deplored Russian aggression while stressing the need to abide by international law and UN Charter.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
